phase readout
saveNCT07720921: Neoadjuvant Disitamab Vedotin, Toripalimab, and Radiotherapy for High-risk UTUC ( LUXUS07.1 )
NOT_YET_RECRUITINGupdated 23h ago
community read0 votes
Sponsor: Peking University First Hospital. Phase: PHASE2. Conditions: Urothelial Carcinoma of the Renal Pelvis and Ureter, Neoadjuvant Therapy
view source ↗
comments(0)
5-min edit window · permanent after that